Bristol-Myers Squibb, Carvana and a few other major stocks post gains in today's pre-market session

US stock futures traded higher this morning after posting gains in the previous session. Here are some prominent stocks moving higher in today's pre-market trading session.

Spectrum Pharmaceuticals, Inc. SPPI rose 19.7% to $1.55 in premarket trading. The United States Food and Drug Administration has approved the injection of the company's main active ingredient ROLVEDON (eflapegrastim-xnst) to reduce the incidence of infection, which manifests as febrile neutropenia. Shares of Faraday Future Intelligent Electric Inc. FFIE rose 11.7% to $1.24 in premarket trading after jumping about 22% on Friday. WeTrade Group, Inc. WETG gained 10.1% to $1.75 in premarket trading after jumping around 17% on Friday. AST SpaceMobile, Inc. ASTS rose 7.8% to $11.60 in premarket trading after gaining more than 7% on Friday. Bristol-Myers Squibb Company BMY rose 7% to $75.04 in premarket trading. The FDA has approved Bristol Myers Squibb Co.'s Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate to severe plaque psoriasis that is a candidate for systemic therapy or phototherapy. Atlantic Equities kept Bristol-Myers Squibb overweight and raised the price target from $83 to $87. Nu Holdings Ltd. NU rose 6.3% to $5.73 in premarket trading after gaining more than 6% on Friday. Carvana Co. CVNA rose 5.4% to $38.60 in premarket trading. Piper Sandler moved Carvana from neutral to overweight and lowered the price target from $98 to $73. Deutsche Bank Aktiengesellschaft DB climbed 4.4% to $9.35 in premarket trading. Cazoo Group Ltd CZOO gained 4% to $0.71 in premarket trading. The company recently announced that it would end its operations in mainland Europe to focus on the main UK market.

Also see this: US Stock Futures Signal Higher Start on Wall Street; Crude oil rises.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.